176 related articles for article (PubMed ID: 16628667)
1. Tailoring antiviral therapy in hepatitis C.
Davis GL
Hepatology; 2006 May; 43(5):909-11. PubMed ID: 16628667
[No Abstract] [Full Text] [Related]
2. Practical consequences of hepatitis C virus quasispecies for target-specific antivirals.
Fanning LJ
J Infect Dis; 2008 Sep; 198(6):797-9. PubMed ID: 18637751
[No Abstract] [Full Text] [Related]
3. Novel hepatitis C drugs in current trials.
Kronenberger B; Welsch C; Forestier N; Zeuzem S
Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
[TBL] [Abstract][Full Text] [Related]
4. ["Hepatitis C awareness, searching for it and referral for therapy"].
Zeuzem S
MMW Fortschr Med; 2006 Apr; 148(16):8. PubMed ID: 16688939
[No Abstract] [Full Text] [Related]
5. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin: is it a mutagen for hepatitis C virus?
Perelson AS; Layden TJ
Gastroenterology; 2007 May; 132(5):2050-2. PubMed ID: 17484896
[No Abstract] [Full Text] [Related]
7. [BMS-790 052 - an oral antiviral hepatitis C antiviral in the pipeline].
Schmitz J
Pharm Unserer Zeit; 2011 Jan; 40(1):8-9. PubMed ID: 21194074
[No Abstract] [Full Text] [Related]
8. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
9. New antiviral therapies for hepatitis C.
O'Leary J; Chung RT
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):265-74. PubMed ID: 14695693
[No Abstract] [Full Text] [Related]
10. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
11. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
Watashi K; Metselaar HJ; van der Laan LJ
Liver Transpl; 2008 Mar; 14(3):265-7. PubMed ID: 18306373
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus (HCV) therapies special thematic issue: call for papers.
Georg GI; Wang S
J Med Chem; 2013 Jan; 56(2):387. PubMed ID: 23294104
[No Abstract] [Full Text] [Related]
14. Treatment and vaccination for hepatitis C: present and future.
Jawaid A; Khuwaja AK
J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
Trepanier JB; Tanner JE; Alfieri C
Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
[TBL] [Abstract][Full Text] [Related]
16. Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?
Shire N; Koziel MJ
Clin Infect Dis; 2004 Dec; 39(12):1761-3. PubMed ID: 15578396
[No Abstract] [Full Text] [Related]
17. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
J Hepatol; 2006 Feb; 44(2):411-21. PubMed ID: 16364491
[No Abstract] [Full Text] [Related]
18. Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future.
Wong JB
Hepatology; 2002 Jul; 36(1):252-4. PubMed ID: 12085373
[No Abstract] [Full Text] [Related]
19. Introduction to hepatitis C virus (HCV) therapies special thematic issue.
Meanwell NA; Watkins WJ
J Med Chem; 2014 Mar; 57(5):1625-6. PubMed ID: 24484173
[No Abstract] [Full Text] [Related]
20. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
